Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders

Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders

Serotonin (5-HT) plays an important role in the regulation of several basic functions of the central and peripheral nervous system. Among the 5-HT receptors, serotonin-6 (5-HT<sub>6</sub>) receptor has been an area of substantial research. 5-HT<sub>6</sub> receptor is a G-pro...

Full description

Bibliographic Details
Main Authors:	Ramakrishna Nirogi, Pradeep Jayarajan, Anil Shinde, Abdul Rasheed Mohammed, Venkata Ramalingayya Grandhi, Vijay Benade, Vinod Kumar Goyal, Renny Abraham, Venkat Jasti, Jeffrey Cummings
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Biomolecules
Subjects:	clinical trials 5-HT<sub>6</sub> receptor antagonist avisetron cerlapirdine idalopirdine intepirdine
Online Access:	https://www.mdpi.com/2218-273X/13/2/309

Similar Items

Intepirdine as adjunctive therapy to donepezil for mild‐to‐moderate Alzheimer's disease: A randomized, placebo‐controlled, phase 3 clinical trial (MINDSET)
by: Frederick M. Lang, et al.
Published: (2021-01-01)

An international, randomized, placebo‐controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY‐DLB)
by: Frederick M. Lang, et al.
Published: (2021-01-01)

Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study
by: Ramakrishna Nirogi, et al.
Published: (2022-01-01)

Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties
by: Vittorio Canale, et al.
Published: (2021-06-01)

Blockade of Serotonin 5-HT<sub>6</sub> Receptor Constitutive Activity Alleviates Cognitive Deficits in a Preclinical Model of Neurofibromatosis Type 1
by: Emilie Doucet, et al.
Published: (2021-09-01)

New Triazine Derivatives as Serotonin 5-HT<sub>6</sub> Receptor Ligands
by: Dorota Łażewska, et al.
Published: (2023-01-01)

Structure, Function, and Pharmaceutical Ligands of 5-Hydroxytryptamine 2B Receptor
by: Qing Wang, et al.
Published: (2021-01-01)

Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT<sub>1A</sub> Serotonin Receptor Antagonists
by: Kinga Ostrowska, et al.
Published: (2021-02-01)

Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents
by: Elżbieta Żmudzka, et al.
Published: (2022-12-01)

In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs
by: Blessy George, et al.
Published: (2021-06-01)

5-HT Receptors and Temperature Homeostasis
by: Irina P. Voronova
Published: (2021-12-01)

Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties
by: Margherita Mastromarino, et al.
Published: (2022-02-01)

Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease
by: Joachim Neumann, et al.
Published: (2023-03-01)

A Novel Antibody Targeting the Second Extracellular Loop of the Serotonin 5-HT2A Receptor Inhibits Platelet Function
by: Jean E. M. Ramirez, et al.
Published: (2022-08-01)

Impact of the Substitution Pattern at the Basic Center and Geometry of the Amine Fragment on 5-HT<sub>6</sub> and D<sub>3</sub>R Affinity in the 1<i>H</i>-Pyrrolo[3,2-<i>c</i>]quinoline Series
by: Katarzyna Grychowska, et al.
Published: (2023-01-01)

Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure–Activity Relationship Studies
by: Kapil Kumar Goel, et al.
Published: (2023-08-01)

Anxiolytic-like activity of serotonin-3 receptor antagonist: In-silico molecular modeling, drug-likeness and evaluation of anxiolytic activity
by: Venkatesha Perumal Ramachandran, et al.
Published: (2022-06-01)

<i>N</i>-Skatyltryptamines—Dual 5-HT<sub>6</sub>R/D<sub>2</sub>R Ligands with Antipsychotic and Procognitive Potential
by: Agata Hogendorf, et al.
Published: (2021-07-01)

Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D<sub>2</sub>-Serotonin 5-HT<sub>1A</sub> Heteromers
by: Sylwia Łukasiewicz
Published: (2021-03-01)

Expression of the Human Serotonin 5-HT<sub>7</sub> Receptor Rescues Phenotype Profile and Restores Dysregulated Biomarkers in a <i>Drosophila melanogaster</i> Glioma Model
by: Florestan Courant, et al.
Published: (2022-04-01)

The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus—PKCε-Mediated Signaling in the Early Hippocampus
by: Sreyashi Samaddar, et al.
Published: (2022-02-01)

Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor
by: Jieon Lee, et al.
Published: (2021-06-01)

Multitargeting the Action of 5-HT<sub>6</sub> Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?
by: Kinga Czarnota-Łydka, et al.
Published: (2022-08-01)

Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus
by: Rosa Sparaco, et al.
Published: (2022-10-01)

Pathological Insight into 5-HT<sub>2B</sub> Receptor Activation in Fibrosing Interstitial Lung Diseases
by: Anna Löfdahl, et al.
Published: (2020-12-01)

Dopamine D<sub>2</sub> and Serotonin 5-HT<sub>1A</sub> Dimeric Receptor-Binding Monomeric Antibody scFv as a Potential Ligand for Carrying Drugs Targeting Selected Areas of the Brain
by: Agata Kowalik, et al.
Published: (2022-05-01)

Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
by: Taryn Bosquez-Berger, et al.
Published: (2023-08-01)

Living-Cell Diffracted X-ray Tracking Analysis Confirmed Internal Salt Bridge Is Critical for Ligand-Induced Twisting Motion of Serotonin Receptors
by: Kazuhiro Mio, et al.
Published: (2021-05-01)

Effects of a <i>Cc2d1a/Freud-1 Knockdown</i> in the Hippocampus on Behavior, the Serotonin System, and BDNF
by: Elena M. Kondaurova, et al.
Published: (2021-12-01)

Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats
by: Mónica García-Domingo, et al.
Published: (2022-05-01)

Binding and functional structure-activity similarities of 4-substituted 2,5-dimethoxyphenyl isopropylamine analogues at 5-HT2A and 5-HT2B serotonin receptors
by: Prithvi Hemanth, et al.
Published: (2023-01-01)

T Lymphocyte Serotonin 5-HT<sub>7</sub> Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients
by: Flora Reverchon, et al.
Published: (2022-09-01)

Serotonin Pathway in Cancer
by: Pragathi Balakrishna, et al.
Published: (2021-01-01)

Effect of Palonosetron in the Prevention of Spinal Anaesthesia-induced Hypotension and Bradycardia: A Randomised Controlled Trial
by: Devulapalli Janardhana Pradeep, et al.
Published: (2023-09-01)

Skin Vascular Resistance Decreases during 5-HT-Induced Hypotension in the Rat
by: Benjamin Butler, et al.
Published: (2023-02-01)

The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice
by: Nermin Eissa, et al.
Published: (2021-02-01)

Optimization of Sb<sub>2</sub>S<sub>3</sub> Nanocrystal Concentrations in P<sub>3</sub>HT: PCBM Layers to Improve the Performance of Polymer Solar Cells
by: E. M. Mkawi, et al.
Published: (2021-06-01)

Monitoring of Animal Feed Contamination by Mycotoxins: Results of Five Years of Official Control by an Accredited Italian Laboratory
by: Cinzia Franchino, et al.
Published: (2024-01-01)

The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2–GATA4 Signaling Pathway
by: Kana Shimizu, et al.
Published: (2021-12-01)

New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics Simulations
by: Giovanni Bolcato, et al.
Published: (2020-05-01)